The trading activity of members of Congress is closely monitored and investors are looking to see which Magnificent Seven stocks are most loved and which large-cap names are being bought and sold. When it comes to a member of Congress buying up shares of small-cap stocks, investors may pay even closer attention. • Genprex stock is among today’s weakest performers. What’s behind GNPX decline?Congressman Buys Small-Cap Stocks AgainCongressman Tim Moore (R-N.C.) made multiple trades in 2025, including buying s ...

Core Insights - Congressman Tim Moore has made significant stock purchases in Hyster-Yale Inc, a small cap lift truck company, amid notable market activity and scrutiny [1][4][6] Group 1: Stock Transactions - Moore disclosed purchases of Hyster-Yale shares totaling between $145,000 and $350,000, with the company's market capitalization around $620 million [2] - His previous transactions included buying $80,000 to $200,000 in shares in October and selling between $100,000 and $250,000 later in the month [4] - Recent purchases did not include any sales, but the stock price surged from $28.12 to $35.03 following the news of his transactions [5] Group 2: Company Background - Hyster-Yale has a history of signing government contracts, which raises questions about the implications of Moore's trades [5] - Moore also made a notable purchase of Genprex shares, a clinical stage gene therapy company with a market capitalization of less than $10 million, indicating a trend towards investing in smaller companies [6] Group 3: Market Reaction - The stock of Hyster-Yale experienced a significant increase in value following the announcement of Moore's purchases, highlighting the potential impact of political figures on stock prices [5]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Olema Pharmaceuticals, Inc. (OLMA) has seen a substantial increase of 213%, trading at $26.68 - Diginex Limited (DGNX) is up 12%, currently priced at $15.25 - Gorilla Technology Group Inc. (GRRR) has risen by 11%, trading at $14.05 - Amer Sports, Inc. (AS) is up 9%, priced at $33.47 - Click Holdings Limited (CLIK) has increased by 9%, trading at $7.38 - Beamr Imaging Ltd. (BMR) is up 9%, currently at $2.14 - James Hardie Industries plc (JHX) has risen by 8%, trading at $18.22 - Arvinas, Inc. (ARVN) is up 8%, priced at $12.00 - Axalta Coating Systems Ltd. (AXTA) has increased by 7%, trading at $30.28 - Genprex, Inc. (GNPX) is up 6%, currently at $4.31 [3] Premarket Losers - LifeMD, Inc. (LFMD) has decreased by 22%, trading at $3.65 - Alpha Technology Group Limited (ATGL) is down 21%, currently priced at $17.00 - Intellinetics, Inc. (INLX) has fallen by 19%, trading at $7.25 - Energizer Holdings, Inc. (ENR) is down 16%, priced at $20.00 - Invivyd, Inc. (IVVD) has decreased by 14%, currently at $2.42 - BellRing Brands, Inc. (BRBR) is down 12%, trading at $22.30 - Sadot Group Inc. (SDOT) has fallen by 9%, currently priced at $3.99 - CEVA, Inc. (CEVA) is down 8%, trading at $21.60 - Helmerich & Payne, Inc. (HP) has decreased by 7%, currently at $25.44 - Opendoor Technologies Inc. (OPEN) is down 5%, trading at $7.39 [4]

Core Insights - U.S. stock futures showed slight gains, with Dow futures up approximately 0.1% [1] - Netflix, Inc. reported disappointing third-quarter results, leading to a significant drop in its stock price [1][2] Company Performance - Netflix's third-quarter revenue reached $11.51 billion, reflecting a year-over-year increase of 17.2%, but fell short of the consensus estimate of $11.514 billion [2] - The company's earnings per share (EPS) were reported at $5.87, missing the consensus estimate of $6.97 [2] - Following the earnings report, Netflix shares fell by 6.9% to $1,156.00 in pre-market trading [2] Other Company Movements - Alector, Inc. experienced a drastic decline of 57.6% to $1.36 after announcing the discontinuation of a drug extension and workforce reduction [4] - Newegg Commerce, Inc. saw a drop of 22.6% to $38.70, following a 5% decline the previous day [4] - Terns Pharmaceuticals, Inc. fell 13.3% to $7.00 after disappointing Phase 2 trial results [4] - Aveanna Healthcare Holdings Inc. shares decreased by 11.9% to $9.01 due to a secondary stock offering [4] - Critical Metals Corp. declined 11.3% to $14.44 after announcing a share offering [4] - Bgin Blockchain Limited dropped 9.5% to $4.49, continuing a downward trend [4] - Genprex, Inc. fell 8.7% to $10.50 after a reverse stock split [4] - Texas Instruments Incorporated's stock declined by 7.7% to $167.00 following lower-than-expected fourth-quarter guidance [4] - Almonty Industries Inc. saw a 7.5% decline to $7.75 after a previous drop [4]

Group 1: Market Overview - U.S. stock futures showed slight gains, with Dow futures up approximately 0.1% on Wednesday [1] Group 2: Netflix Financial Results - Netflix reported third-quarter revenue of $11.51 billion, reflecting a year-over-year increase of 17.2%, but fell short of the Street consensus estimate of $11.514 billion [2] - The company reported earnings per share of $5.87, which also missed the Street consensus estimate of $6.97 [2] - Following the earnings report, Netflix shares dropped 6.9% to $1,156.00 in pre-market trading [2] Group 3: Other Stocks in Pre-Market Trading - Alector, Inc. saw a significant decline of 57.6% to $1.36 after announcing the discontinuation of an open-label extension for Latozinemab and a workforce reduction of about 49% [4] - Newegg Commerce, Inc. fell 22.6% to $38.70 after a 5% decline on Tuesday [4] - Terns Pharmaceuticals, Inc. dipped 13.3% to $7.00 after announcing that Phase 2 topline results for TERN-601 did not meet the threshold for further development [4] - Aveanna Healthcare Holdings Inc. shares declined 11.9% to $9.01 following the pricing of a secondary offering of common stock [4] - Critical Metals Corp. dropped 11.3% to $14.44 after a previous 17% decline due to an offering of 18.03 million shares [4] - Bgin Blockchain Limited declined 9.5% to $4.49 after a 17% drop on Tuesday [4] - Genprex, Inc. fell 8.7% to $10.50 after implementing a 1-for-50 reverse stock split, reducing outstanding shares to 1,004,326 [4] - Texas Instruments Incorporated declined 7.7% to $167.00 after issuing fourth-quarter EPS and sales guidance below analyst estimates [4] - Almonty Industries Inc. fell 7.5% to $7.75 after a 7% decline on Tuesday [4]

分组1 - J.B. Hunt Transport Services, Inc. reported third-quarter earnings of $1.76 per share, exceeding the consensus estimate of $1.47 [1] - The company's quarterly revenue reached $3.05 billion, surpassing the Street estimate of $3.02 billion [1] - Following the earnings report, J.B. Hunt Transport shares increased by 12.9% to $156.80 in pre-market trading [1] 分组2 - Linkage Global Inc experienced a significant gain of 210%, reaching $5.11 in pre-market trading [4] - MIRA Pharmaceuticals surged 79.8% to $2.37 after revealing new preclinical results for its proprietary compound [4] - Vivakor, Inc. saw a 62.2% increase to $0.4789 after announcing a $40 million credit facility [4] 分组3 - Pinnacle Food Group Limited shares fell 25.2% to $3.42 after a previous jump of 139% [4] - Hyperfine, Inc. dipped 14.1% to $1.89 following preliminary revenue results below estimates [4] - NIO Inc. declined 8.5% to $6.24 in pre-market trading [4]

Market Movements - Australian Oilseeds Holdings Limited Warrant (NASDAQ:COOTW) surged by 494.86% to $0.18 with a trading volume of 3,759,243, while its ordinary shares (COOT) increased by 244.87% to $3.32 with a trading volume of 167,502,947, despite facing a Nasdaq notification regarding non-compliance with the minimum stockholders' equity requirement of $10 million [1][4] - Genprex, Inc. (NASDAQ:GNPX) saw a 193.90% increase in its stock price to $0.74 with a trading volume of 825,729,912, driven by anticipation of promising preclinical data on its Reqorsa® Gene Therapy, which targets ALK-EML4 positive translocated non-small cell lung cancer [1][4] - Omeros Corporation (NASDAQ:OMER) experienced a 170.73% increase in its stock price to $11.1 with a trading volume of 107,994,321, following a significant licensing agreement with Novo Nordisk valued at up to $2.1 billion, granting exclusive global rights to develop and commercialize Omeros' MASP-3 inhibitor [1][4] Investor Interest - Bonk, Inc. Warrant (BNKKW) experienced a 125.16% price increase to $0.17 with a volume of 127,897, indicating investor interest in the company's prospects [2] - The reasons behind these surges include positive clinical trial results, strategic corporate developments, and broader market trends favoring these sectors [2] - The market environment reflects significant investor interest across various sectors, including biotechnology and consumer defensive, with analysts closely monitoring these companies for further developments [3]

Market Overview - U.S. stocks experienced gains, with the Nasdaq Composite increasing by over 100 points, the Dow up 0.06% to 46,299.96, the NASDAQ climbing 0.52% to 22,639.61, and the S&P 500 rising 0.33% to 6,666.08 [1] - Communication services shares rose by 1.6%, while health care stocks saw a slight increase of 0.1% [1] Company Performance - Abbott Laboratories' stock fell approximately 2.6% after reporting third-quarter sales of $11.37 billion, slightly below the consensus estimate of $11.40 billion [2] - The company reported adjusted earnings of $1.30, aligning with Wall Street estimates and within management's guidance of $1.28-$1.32 [2] - Abbott narrowed its fiscal 2025 adjusted earnings guidance from a range of $5.10 to $5.20 per share to $5.12 to $5.18 per share, compared to the consensus of $5.15 per share [3] Commodity Market - Oil prices increased by 0.3% to $58.89, while gold rose by 1.2% to $4,213.60 [6] - Silver traded up 1.6% to $51.405, and copper saw a slight increase of 0.1% to $5.0250 [6] Notable Stock Movements - Veritone, Inc. shares surged 68% to $9.19 following new contract wins and an updated Q3 financial outlook [9] - Genprex, Inc. experienced a significant increase of 269% to $0.9208 due to upcoming presentations at a major conference [9] - Omeros Corporation's shares rose 131% to $9.49 after Novo Nordisk acquired its global rights to Zaltenibart [9] - Yueda Digital Holding's shares plummeted 86% to $0.2001 after announcing a $28 million registered direct offering [9] - Largo Inc. shares fell 43% to $1.43 due to a $23.4 million registered direct offering and private placement [9] - Aqua Metals, Inc. shares decreased by 39% to $18.11 after raising $13 million for growth initiatives [9] Economic Indicators - The NY Empire State Manufacturing Index increased by 19.4 points to a reading of 10.7 in October, surpassing market expectations of -1.0 [11]

Market Overview - U.S. stocks experienced gains, with the Nasdaq Composite increasing by over 100 points, the Dow up 0.06% to 46,299.96, the NASDAQ climbing 0.52% to 22,639.61, and the S&P 500 rising 0.33% to 6,666.08 [1] - Communication services shares rose by 1.6%, while health care stocks saw a slight increase of 0.1% [1] Company Performance - Abbott Laboratories' stock fell approximately 2.6% after reporting third-quarter sales of $11.37 billion, slightly below the consensus estimate of $11.40 billion [2] - The company reported adjusted earnings of $1.30, aligning with Wall Street estimates and within the management guidance of $1.28-$1.32 [2] - Abbott narrowed its fiscal 2025 adjusted earnings guidance from a range of $5.10 to $5.20 per share to $5.12 to $5.18 per share, compared to the consensus of $5.15 per share [3] Notable Stock Movements - Veritone, Inc. shares surged 68% to $9.19 following new contract wins and an updated Q3 financial outlook [9] - Genprex, Inc. saw a significant increase of 269% to $0.9208 due to upcoming presentations at a major conference [9] - Omeros Corporation's shares rose 131% to $9.49 after Novo Nordisk acquired its global rights to Zaltenibart [9] - Yueda Digital Holding's shares plummeted 86% to $0.2001 after announcing a $28 million registered direct offering [9] - Largo Inc. shares dropped 43% to $1.43 following the pricing of a $23.4 million registered direct offering and private placement [9] - Aqua Metals, Inc. fell 39% to $18.11 after raising $13 million from an institutional investor [9] Commodity Market - Oil prices increased by 0.3% to $58.89, while gold rose by 1.2% to $4,213.60 [6] - Silver traded up 1.6% to $51.405, and copper saw a slight increase of 0.1% to $5.0250 [6] Economic Indicators - The NY Empire State Manufacturing Index rose by 19.4 points to a reading of 10.7 in October, exceeding market expectations of -1.0 [11]

Market Overview - U.S. stocks experienced an upward trend, with the S&P 500 increasing by 1% on Wednesday, while the Dow rose by 0.84% to 46,657.52 and the NASDAQ climbed 1.19% to 22,788.69 [1] - Real estate shares saw a notable increase of 1.7%, and health care stocks rose by 0.4% on the same day [1] Company Financials - Bank of America reported a net income of $8.5 billion for Q3 fiscal 2025, up from $6.9 billion a year ago, with an EPS of $1.06, surpassing the analyst consensus estimate of $0.94 [2] - The bank's revenue, net of interest expense, increased by 11% year-over-year to $28.24 billion, exceeding the analyst consensus estimate of $27.50 billion [2] Commodity Market - Oil prices increased by 0.4% to $58.96, while gold rose by 1.3% to $4,217.50 [5] - Silver traded up 1.6% to $51.410, whereas copper experienced a slight decline of 0.1% to $5.0225 [5] Stock Movements - Australian Oilseeds Holdings Limited shares surged by 270% to $3.6200 following comments from President Trump regarding potential business terminations with China [8] - Genprex, Inc. saw its shares increase by 173% to $0.6910 due to upcoming presentations at a major cancer therapeutics conference [8] - Omeros Corporation's shares rose by 144% to $10.02 after Novo Nordisk acquired its global rights to Zaltenibart [8] - Conversely, Yueda Digital Holding shares plummeted by 84% to $0.2259 after announcing a $28 million registered direct offering [8] - Largo Inc. shares fell by 45% to $1.39 following the announcement of a $23.4 million registered direct offering and private placement [8] - Aqua Metals, Inc. shares decreased by 37% to $18.72 after raising $13 million from an institutional investor [8] International Markets - European shares were generally higher, with the eurozone's STOXX 600 rising by 0.6% and France's CAC 40 surging by 2.2% [6] - Asian markets closed positively, with Japan's Nikkei 225 increasing by 1.76% and Hong Kong's Hang Seng index jumping by 1.84% [9] Economic Indicators - The NY Empire State Manufacturing Index rose by 19.4 points to a reading of 10.7 in October, surpassing market expectations of -1.0 [10]